Zaltrap (ziv-aflibercept) Injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
ADVERSE REACTIONS
Post Marketing Experience
(added) Cardiac disorders: Cardiac failure, Ejection fraction...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology | Marketing